Cargando…
ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice
Vascular endothelial growth factor (VEGF) and other pro-angiogenic growth factors have been investigated to enhance muscle tissue perfusion and repair in Duchenne muscular dystrophy (DMD). Current understanding is limited by a lack of functional data following in vivo delivery of these growth factor...
Autores principales: | Gutpell, Kelly M., Tasevski, Nikola, Wong, Boaz, Hrinivich, William Thomas, Su, Feng, Hadway, Jennifer, Desjardins, Lise, Lee, Ting-Yim, Hoffman, Lisa Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363921/ https://www.ncbi.nlm.nih.gov/pubmed/28334037 http://dx.doi.org/10.1371/journal.pone.0174315 |
Ejemplares similares
-
Skeletal Muscle Fibrosis in the mdx/utrn+/- Mouse Validates Its Suitability as a Murine Model of Duchenne Muscular Dystrophy
por: Gutpell, Kelly M., et al.
Publicado: (2015) -
Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice
por: Lin, Yiming, et al.
Publicado: (2023) -
Assessment of intratumor hypoxia by integrated (18)F-FDG PET / perfusion CT in a liver tumor model
por: Wang, Yong, et al.
Publicado: (2017) -
Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice
por: Ahmad, Nabeel, et al.
Publicado: (2011) -
Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
por: Liu, Yuanyuan, et al.
Publicado: (2022)